Profile data is unavailable for this security.
About the company
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with diabetes and by healthcare providers. Its Dexcom G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an application on the patient's mobile device to wirelessly transmit glucose information to the cloud and then to applications on the mobile devices of up to five designated recipients. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. Its other products include Dexcom ONE and Dexcom G7.
- Revenue in USD (TTM)2.57bn
- Net income in USD211.70m
- LocationDexcom Inc6340 Sequence DrSAN DIEGO 92121-4356United StatesUSA
- Phone+1 (858) 200-0200
- Fax+1 (302) 636-5454
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|DXCM:NSQ since |
|Australasian Medical & Scientific Ltd||Deal completed||01 Aug 2021||01 Aug 2021Deal completed||-84.93%||--|